SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SGRY

Surgery Partners, Inc. (NASDAQ:SGRY)

US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
$26.78+$0.09 (+0.34%)
 
Market cap
$3.50B
Insider Score
Health Score
Analyst consensus
Listed since
Sep 30, 2015
Market Cap$3.50B+64.4%
Revenue (ttm)$3.36B+2.2%
Net Income-$87.00M+49.2%
EPS-$0.67+50.7%
Shares Out130.88M
PE Ration/a
Forward PE133.81
Dividendn/a
Ex-Dividend Daten/a
Volume1,111,621
Open$26.64
Previous Close$26.69
Day's Range$26.62 - $26.96
52-Week Range$11.41 - $27.23
Beta1.88
AnalystsHold
Price Target$24.00(-10.38%)
Earnings DateMar 1, 2027

About SGRY

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.

Address
310 Seven Springs Way, Brentwood, TN, 37027, US
Market Cap
3.50 billion
Employees
16,000
Industrial Classification
Medical - Care Facilities

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.26M
Bought
$304.71K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
0 Buy5 Hold0 SellAvg target $22.06 (-17.6%)

5 firms rating SGRY in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From SGRY’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+0.34%
5 Days
+0.11%
1 Month
+68.43%
6 Months
+99.85%
1 Year
+64.40%

$SGRY stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SGRY holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SGRY's directors and management

Net Shares Purchased by Insiders−100k−50k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SGRY Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SGRY Revenue by Segment

$1.31BTotal
Surgical Facilities$815.30M62.08%
Supplies$214.10M16.30%
Adjusted Surgical Facilities EBITDA$162.00M12.34%
Professional and medical fees$99.20M7.55%
Transaction and integration costs$22.60M1.72%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New SGRY patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SGRY from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SGRY

DFSVU.S. Small Cap Value Portfolio ETF Class Shares$63.17M
IWMiShares Russell 2000 ETF$57.92M
VTIVanguard Morningstar Total Stock Market ETF$45.38M
VBVanguard Morningstar Small-Cap ETF$40.90M
DFATDimensional - US Targeted Value ETF$32.91M
VBRVanguard Morningstar Small-Cap Value ETF$26.57M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SGRY’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
35.91
Analyst Ratings
32% of score
47
News & Sentiment
20% of score
55

News check: Mixed sentiment: Q3 earnings beat and RBC price target increase offset by Mizuho downgrade to Neutral and valuation concerns.

Recent Insider Activity

Buys
2
Sells
11
Buy Value
$304.71K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XHSState Street SPDR S&P Health Care Services ETF3.07%
MRGRProShares - Merger ETF2.61%
ADDSHedgeye Index Adds ETF2.12%
SMIZZacks Small/Mid Cap ETF1.08%
NIXTResearch Affiliates Deletions ETF0.81%
PLCYEventShares U.S. Legislative Opportunities ETF0.63%
IVSSApplied Finance IVS US SMID ETF0.47%
EBITHarbor AlphaEdge Small Cap Earners ETF (EBIT)0.37%
ISMDInspire Small/Mid Cap ETF0.37%
IHFiShares U.S. Healthcare Providers ETF0.25%
DFSVU.S. Small Cap Value Portfolio ETF Class Shares0.23%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.21%

Weight is the stock’s share of each fund’s holdings.